









Markets
/
Stocks
/
nasdaq-pths
/

Pelthos Therapeutics Ord Shs

PTHS

22.990USD

-0.301-1.29%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

71.06MMarket Cap

LossP/E TTM



Pelthos Therapeutics Ord Shs

22.990

-0.301-1.29%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

You can check out the annual or quarterly balance sheets of Pelthos Therapeutics Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Total equity

Cash, cash equivalents and short-term investments

--14.20M

- Cash and cash equivalents

--14.20M

Receivables

--7.99M

-Accounts and notes receivable

--7.99M

Inventory

--24.10M

Prepaid expenses

--1.55M

Other current assets

--1.92M

Total current assets

--49.76M

Non-current assets

Net Fixed Assets

--13.53M

-Fixed Assets

--13.91M

-Accumulated depreciation

--389.00K

Goodwill and other intangible assets

--63.15M

Total non-current assets

--76.67M

Total assets

--126.43M

Liabilities

Current liabilities

-Other payables

--5.56M

Accrued expenses

--11.89M

Short-term debt and lease liabilities

--0.00

-Short-term debt

--0.00

Deferred liabilities

--1.02M

Other current liabilities

--6.58M

Total current liabilities

--24.77M

Non-current liabilities

Long-term debt and lease liabilities

--2.85M

-Long-term lease liabilities

--2.85M

Deferred liabilities

--1.52M

Other non-current liabilities

--27.70M

Total non-current liabilities

--43.41M

Total liabilities

--68.18M

Shareholders' equity

Common equity

--101.38M

Retained earnings

---43.13M

Capital reserves

--101.38M

Total equity

--58.25M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

